Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Sherlock Biosciences CRISPR SARS-CoV-2 Diagnostic Test Gets FDA Emergency Use Authorization

Sherlock Biosciences CRISPR SARS-CoV-2 Diagnostic Test Gets FDA Emergency Use Authorization

May 07, 2020
|
staff reporter

NEW YORK – Genetic engineering company Sherlock Biosciences said on Thursday that it has received Emergency Use Authorization from the US Food and Drug Administration for its Sherlock CRISPR SARS-CoV-2 kit for the detection of the virus that causes COVID-19.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

What's Popular?

In Business News

  1. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  2. Catalog DNA Merges Molecular Biology, Information Theory to Pursue DNA-Based Computing

    Premium

  3. Ionpath Expanding Sales Force, Investing in Informatics Tools Development

    Premium

  4. Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

  5. M2Gen Expands Partnership With Discovery Life Sciences

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.